SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8001041
Source:
http://linkedlifedata.com/resource/pubmed/id/8001041
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006684
,
umls-concept:C0027051
,
umls-concept:C0205314
,
umls-concept:C0456389
,
umls-concept:C0679622
,
umls-concept:C0752119
,
umls-concept:C1280551
,
umls-concept:C1549649
,
umls-concept:C2349209
pubmed:issue
10
pubmed:dateCreated
1995-1-26
pubmed:abstractText
The aim was to compare the infarct limiting effect of Ro 40-5967 (Ro40), a new calcium antagonist with little negative inotropic activity, with that of verapamil and with ischaemic preconditioning, a potent endogenous cardioprotective mechanism.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/HL17670
,
http://linkedlifedata.com/resource/pubmed/grant/HL27416
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0077427
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers
,
http://linkedlifedata.com/resource/pubmed/chemical/Mibefradil
,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrahydronaphthalenes
,
http://linkedlifedata.com/resource/pubmed/chemical/Verapamil
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0008-6363
pubmed:author
pubmed-author:ReimerK AKA
,
pubmed-author:SchwartzL MLM
,
pubmed-author:Vander HeideR SRS
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1526-32
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:8001041-Animals
,
pubmed-meshheading:8001041-Benzimidazoles
,
pubmed-meshheading:8001041-Blood Pressure
,
pubmed-meshheading:8001041-Calcium Channel Blockers
,
pubmed-meshheading:8001041-Dogs
,
pubmed-meshheading:8001041-Female
,
pubmed-meshheading:8001041-Heart
,
pubmed-meshheading:8001041-Heart Rate
,
pubmed-meshheading:8001041-Male
,
pubmed-meshheading:8001041-Mibefradil
,
pubmed-meshheading:8001041-Myocardial Infarction
,
pubmed-meshheading:8001041-Myocardial Ischemia
,
pubmed-meshheading:8001041-Myocardium
,
pubmed-meshheading:8001041-Tetrahydronaphthalenes
,
pubmed-meshheading:8001041-Verapamil
pubmed:year
1994
pubmed:articleTitle
The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog.
pubmed:affiliation
Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710.
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, Non-U.S. Gov't